Lannett Co Inc ROA 2006-2018 | LCI

Current and historical return on assets (ROA) values for Lannett Co Inc (LCI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Lannett Co Inc ROA for the three months ending September 30, 2018 was 7.39%.
Lannett Co Inc ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.27B $1.26B -17.87%
2018-06-30 $0.03B $1.58B 1.80%
2018-03-31 $0.05B $1.60B 2.84%
2017-12-31 $0.05B $1.66B 2.95%
2017-09-30 $0.04B $1.62B 2.55%
2017-06-30 $-0.00B $1.60B 0.00%
2017-03-31 $-0.00B $1.63B -0.12%
2016-12-31 $-0.02B $1.75B -1.26%
2016-09-30 $-0.02B $1.73B -0.91%
2016-06-30 $0.05B $1.76B 3.17%
2016-03-31 $0.08B $1.75B 6.67%
2015-12-31 $0.12B $1.75B 14.32%
2015-09-30 $0.15B $0.54B 30.53%
2015-06-30 $0.15B $0.51B 33.90%
2015-03-31 $0.14B $0.46B 34.91%
2014-12-31 $0.13B $0.42B 35.08%
2014-09-30 $0.10B $0.37B 30.56%
2014-06-30 $0.06B $0.34B 21.15%
2014-03-31 $0.04B $0.31B 16.49%
2013-12-31 $0.02B $0.27B 9.68%
2013-09-30 $0.01B $0.18B 2.94%
2013-06-30 $0.01B $0.17B 8.42%
2013-03-31 $0.01B $0.17B 6.88%
2012-12-31 $0.01B $0.17B 5.80%
2012-09-30 $0.01B $0.16B 4.66%
2012-06-30 $0.00B $0.14B 2.71%
2012-03-31 $0.00B $0.15B 0.67%
2011-12-31 $-0.00B $0.15B -0.68%
2011-09-30 $0.00B $0.15B 0.00%
2011-06-30 $0.00B $0.15B 0.00%
2011-03-31 $0.01B $0.14B 3.60%
2010-12-31 $0.01B $0.14B 5.13%
2010-09-30 $0.01B $0.13B 3.77%
2010-06-30 $0.01B $0.14B 6.12%
2010-03-31 $0.01B $0.13B 5.51%
2009-12-31 $0.01B $0.13B 4.90%
2009-09-30 $0.01B $0.12B 6.68%
2009-06-30 $0.01B $0.13B 5.11%
2009-03-31 $0.00B $0.12B 3.49%
2008-12-31 $0.00B $0.11B 1.80%
2008-09-30 $-0.00B $0.12B -0.93%
2008-06-30 $-0.00B $0.11B -1.92%
2008-03-31 $-0.01B $0.10B -4.90%
2007-12-31 $-0.01B $0.10B -10.38%
2007-09-30 $-0.01B $0.10B -8.35%
2007-06-30 $-0.01B $0.11B -7.32%
2007-03-31 $-0.00B $0.12B -3.65%
2006-12-31 $0.00B $0.11B 3.76%
2006-09-30 $0.00B $0.11B 3.85%
2006-06-30 $0.01B $0.11B 4.93%
2006-03-31 $-0.00B $0.11B -2.03%
2005-12-31 $-0.03B $0.10B -32.74%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.190B $0.685B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.409B 11.39
Zoetis (ZTS) United States $42.496B 29.09
Grifols (GRFS) Spain $12.892B 15.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.479B 12.17
Ionis Pharmaceuticals (IONS) United States $7.282B 0.00
Tilray (TLRY) United States $6.999B 0.00
Neurocrine Biosciences (NBIX) United States $6.469B 1426.80
Nektar Therapeutics (NKTR) United States $6.319B 9.06
Catalent (CTLT) United States $5.036B 21.12
Impax Laboratories (AMRX) United States $4.810B 0.00
Sage Therapeutics (SAGE) United States $4.782B 0.00
United Therapeutics (UTHR) United States $4.703B 7.69
Loxo Oncology (LOXO) United States $4.251B 0.00
TESARO (TSRO) United States $4.056B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.483B 12.90
FibroGen (FGEN) United States $3.361B 0.00
USANA Health Sciences (USNA) United States $2.895B 24.64
Endo (ENDP) Ireland $2.286B 3.50
Xencor (XNCR) United States $2.031B 0.00
Endocyte (ECYT) United States $1.957B 0.00
Heron Therapeutics (HRTX) United States $1.948B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.861B 251.44
Corcept Therapeutics (CORT) United States $1.860B 27.31
Ironwood Pharmaceuticals (IRWD) United States $1.810B 0.00
Zogenix (ZGNX) United States $1.739B 0.00
Aerie Pharmaceuticals (AERI) United States $1.737B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.697B 0.00
PTC Therapeutics (PTCT) United States $1.697B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.433B 20.15
Tricida (TCDA) United States $1.340B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.286B 0.00
Portola Pharmaceuticals (PTLA) United States $1.252B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.238B 0.00
TherapeuticsMD (TXMD) United States $0.921B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.906B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.807B 0.00
ImmunoGen (IMGN) United States $0.772B 0.00
Radius Health (RDUS) United States $0.719B 0.00
Forty Seven (FTSV) United States $0.712B 0.00
Collegium Pharmaceutical (COLL) United States $0.603B 0.00
Karyopharm Therapeutics (KPTI) United States $0.584B 0.00
Siga Technologies (SIGA) United States $0.558B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.513B 0.00
ChemoCentryx (CCXI) United States $0.507B 40.12
Flexion Therapeutics (FLXN) United States $0.505B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.446B 26.29
GlycoMimetics (GLYC) United States $0.446B 0.00
Akebia Therapeutics (AKBA) United States $0.435B 0.00
Xeris Pharmaceuticals (XERS) United States $0.420B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Dermira (DERM) United States $0.417B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
CASI Pharmaceuticals (CASI) United States $0.405B 0.00
Tyme Technologies (TYME) United States $0.398B 0.00
KalVista Pharmaceuticals (KALV) United States $0.390B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Translate Bio (TBIO) United States $0.370B 0.00
ArQule (ARQL) United States $0.351B 0.00
OptiNose (OPTN) United States $0.340B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.336B 0.00
Majesco Entertainment (PTE) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.316B 0.00
Tapimmune (MRKR) United States $0.309B 0.00
Minerva Neurosciences (NERV) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.299B 0.00
Aratana Therapeutics (PETX) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.261B 0.00
Depomed (ASRT) United States $0.259B 9.64
Verrica Pharmaceuticals (VRCA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
IMV INC (IMV) Canada $0.245B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.240B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.205B 0.00
Zafgen (ZFGN) United States $0.191B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.175B 0.00
Opexa Therapeutics (ACER) United States $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.172B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
ContraFect (CFRX) United States $0.165B 0.00
Recro Pharma (REPH) United States $0.164B 0.00
Nature's Sunshine Products (NATR) United States $0.162B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.159B 0.00
Neon Therapeutics (NTGN) United States $0.158B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.147B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
Ardelyx (ARDX) United States $0.134B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.133B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
MediWound (MDWD) Israel $0.130B 0.00
Cardiome Pharma (CORV) Canada $0.129B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.115B 0.00
DURECT (DRRX) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
ProNAi Therapeutics (SRRA) Canada $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.102B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.081B 0.00
Immune Design (IMDZ) United States $0.076B 0.00
Achaogen (AKAO) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.075B 7.36
CTI BioPharma (CTIC) United States $0.072B 0.00
Otonomy (OTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Melinta Therapeutics (MLNT) United States $0.066B 0.00
BioLineRx (BLRX) Israel $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.062B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
ProPhase Labs (PRPH) United States $0.036B 0.00
Capnia (SLNO) United States $0.035B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Novan (NOVN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Trillium Therapeutics (TRIL) Canada $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
PharmAthene (ALT) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.05
ESSA Pharma (EPIX) Canada $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 1.40
Regulus Therapeutics (RGLS) United States $0.012B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Skyline Medical (AIPT) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Aradigm (ARDM) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00